The purpose of this study is to evaluate the relationship between insulin resistance (IR) and myocardial tissue abnormalities. The study will focus on a patient population, South Asians, with a high prevalence of IR.
Age range
20 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Identifying patients with high fibrosis levels using peripheral blood samples
Timeframe: Blood samples drawn once at baseline visit
Insulin Sensitivity measured by OGTT
Timeframe: OGTT done at baseline/ first visit
Insulin Sensitivity measured by Fasting Lipid Panel
Timeframe: Lipid Panel done at baseline/ first visit
Left ventricular volume
Timeframe: CMR done at baseline visit
Left ventricular mass
Timeframe: CMR done at baseline visit
Ejection fraction %
Timeframe: CMR done at baseline visit
Myocardial tagging for strain analysis
Timeframe: CMR done at baseline visit
Assessing diffuse fibrosis via T1 mapping
Timeframe: CMR done at baseline visit
Assessing level of edema via T2 mapping
Timeframe: CMR done at baseline visit